Safety and Efficacy of GS-4774 in Patients with Chronic Hepatitis B on Oral Antiviral Therapy

被引：0

作者：

Lok, Anna S. ^{[1
]}

Pan, Calvin Q. ^{[2
]}

Han, Steven-Huy B. ^{[3
]}

Trinh, Huy N. ^{[4
]}

Fessel, Jeffrey ^{[5
]}

Rodell, Tim ^{[6
]}

Massetto, Benedetta ^{[7
]}

Nguyen, Anh-Hoa ^{[7
]}

Gaggar, Anuj ^{[7
]}

Subramanian, Mani ^{[7
]}

McHutchison, John G. ^{[7
]}

Ferrari, Carlo ^{[8
]}

Lee, Hannah ^{[9
]}

Gordon, Stuart C. ^{[10
]}

Gane, Edward J. ^{[11
]}

机构：

[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[2] Med Procare PLLC, Flushing, NY USA

[3] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

[4] San Jose Gastroenterol, San Jose, CA USA

[5] Kaiser Permanente, San Francisco, CA USA

[6] Globeimmune, Louisville, CO USA

[7] Gilead Sci Inc, Foster City, CA 94404 USA

[8] Univ Parma, I-43100 Parma, Italy

[9] Tufts Med Ctr, Boston, MA USA

[10] Henry Ford Hosp, Detroit, MI 48202 USA

[11] Auckland Gen Hosp, Auckland, New Zealand

来源：

HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2015

引用

页码：1191A / 1191A

页数：1

共 50 条

[21] Discontinuation of antiviral therapy in chronic hepatitis B patients
Medas, Renato
Liberal, Rodrigo
Macedo, Guilherme
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (24) : 6979 - 6986
[22] Antiviral therapy in patients with chronic hepatitis B and cirrhosis
Lai, CJ
Terrault, NA
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 629 - +
[23] Safety and efficacy of antiviral therapy in patients with decompensated cirrhosis associated with chronic hepatitis C infection
Lim, JK
Imperial, JC
JOURNAL OF HEPATOLOGY, 2005, 42 : 211 - 211
[24] Safety and efficacy of antiviral therapy in patients with decompensated cirrhosis associated with chronic hepatitis C infection
Lim, JK
Imperial, JC
GASTROENTEROLOGY, 2005, 128 (04) : A719 - A719
[25] Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
Xu, Kerui
Liu, Li-Ming
Farazi, Paraskevi A.
Wang, Hongmei
Rochling, Fedja A.
Watanabe-Galloway, Shinobu
Zhang, Jian-Jun
GLOBAL HEALTH ACTION, 2018, 11 (01)
[26] Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
Janssen, Harry L. A.
Brunetto, Maurizia R.
Kim, Yoon Jun
Ferrari, Carlo
Massetto, Benedetta
Nguyen, Anh-Hoa
Joshi, Adarsh
Woo, Jacky
Lau, Audrey H.
Gaggar, Anuj
Subramanian, G. Mani
Yoshida, Eric M.
Ahn, Sang Hoon
Tsai, Naoky C. S.
Fung, Scott
Gane, Edward J.
JOURNAL OF HEPATOLOGY, 2018, 68 (03) : 431 - 440
[27] Antiviral Therapy of Chronic Hepatitis B
van Boemmel, Florian
Berg, Thomas
INTERVIROLOGY, 2014, 57 (3-4) : 171 - 180
[28] Antiviral therapy of chronic hepatitis B
Zoulim, Fabien
ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 206 - 215
[29] Antiviral Therapy for Chronic Hepatitis B
Jafri, Syed-Mohammed R.
Lok, Anna Suk-Fong
CLINICS IN LIVER DISEASE, 2010, 14 (03) : 425 - +
[30] Antiviral Therapy for Chronic Hepatitis B
Lee, Kwan Sik
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (08): : 831 - 837

← 1 2 3 4 5 →